Dan Leonard Analyst PerformanceManaging Director, Research Analyst at UBS GroupDan Leonard is a stock analyst at UBS Group focused in the medical sector, covering 29 publicly traded companies. Over the past year, Dan Leonard has issued 35 stock ratings, including buy, hold, and sell recommendations. While full access to Dan Leonard's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Dan Leonard's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings102 Last 10 YearsBuy Recommendations62.75% 64 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution102RatingsDistribution of strong buy, buy, hold, and sell ratings by Dan Leonard.RatingPercentageCount Strong Buy0.0%0 ratings Buy62.7%64 ratings Hold36.3%37 ratings Sell1.0%1 ratingsOut of 102 total stock ratings issued by Dan Leonard at UBS Group, the majority (62.7%) have been Buy recommendations, followed by 36.3% Hold and 1.0% Sell.Best & Worst CallsBest Call000.0%GHMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CDNAApr 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ51.7% of companies on NASDAQ15 companiesNYSE48.3% of companies on NYSE14 companiesDan Leonard, an analyst at UBS Group, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical28 companies96.6%Computer and Technology1 company3.4%Dan Leonard of UBS Group specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES7 companies24.1%MED - BIOMED/GENE7 companies24.1%MED INSTRUMENTS6 companies20.7%MED PRODUCTS2 companies6.9%INSTRU - SCIENTFC1 company3.4%MEDICAL INFO SYS1 company3.4%MED/DENTAL - SUPP1 company3.4%MED - OUTP/HM CRE1 company3.4%SURGICAL & MEDICAL INSTRUMENTS1 company3.4%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company3.4%MEDICAL LABORATORIES1 company3.4% Dan Leonard's Ratings History at UBS Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBRKRBruker5/7/2026Boost Price Target$42.30$45.00Neutral$0.0000.00% ROIDHRDanaher4/22/2026Lower Price Target$184.11$250.00Buy$0.0000.00% ROIAAgilent Technologies2/26/2026Lower Price Target$118.76$165.00Buy$0.0000.00% ROIRGENRepligen2/25/2026Lower Price Target$131.74$195.00Buy$0.0000.00% ROICRLCharles River Laboratories International2/25/2026Boost Price Target$168.32$175.00Neutral$0.0000.00% ROITXG10x Genomics2/20/2026Boost Price Target$19.19$20.00Neutral$0.0000.00% ROIBRKRBruker2/13/2026Reiterated Rating$37.09$49.00Neutral$0.0000.00% ROIAVTRAvantor2/12/2026Reiterated Rating$9.42$10.50Neutral$0.0000.00% ROIWATWaters2/10/2026Lower Price Target$329.29$370.00Neutral$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$184.48$240.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TECHBio-Techne2/5/2026Reiterated Rating$68.67$79.00Buy$0.0000.00% ROITMOThermo Fisher Scientific1/30/2026Reiterated Rating$579.46$615.00Neutral$0.0000.00% ROIGHGuardant Health1/30/2026Reiterated Rating$111.21$175.00Buy$0.0000.00% ROIRGENRepligen1/16/2026Boost Price Target$161.69$200.00Buy$0.0000.00% ROIIQVIQVIA1/8/2026Boost Price Target$244.33$280.00Buy$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$159.11$180.00Buy$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$14.70$14.00Neutral$0.0000.00% ROITECHBio-Techne11/6/2025Boost Price Target$57.48$70.00Buy$0.0000.00% ROIBRKRBruker11/4/2025Boost Price Target$38.71$43.00Neutral$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$94.58$110.00Buy$0.0000.00% ROIIQVIQVIA10/29/2025Boost Price Target$219.01$250.00Buy$0.0000.00% ROIWSTWest Pharmaceutical Services10/24/2025Boost Price Target$307.07$355.00Buy$0.0000.00% ROITMOThermo Fisher Scientific10/23/2025Boost Price Target$568.42$590.00Neutral$0.0000.00% ROIAAgilent Technologies10/8/2025Upgrade$138.56$170.00Buy$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$62.55$80.00Buy$0.0000.00% ROITXG10x Genomics8/8/2025Boost Price Target$12.07$13.00Neutral$0.0000.00% ROIEXASExact Sciences8/7/2025Lower Price Target$41.32$53.00Neutral$0.0000.00% ROICERTCertara8/7/2025Lower Price Target$11.31$15.00Buy$0.0000.00% ROIMEDPMedpace7/29/2025Downgrade$453.05$305.00Sell$0.0000.00% ROITMOThermo Fisher Scientific7/24/2025Boost Price Target$478.05$500.00Neutral$0.0000.00% ROIDHRDanaher7/23/2025Lower Price Target$198.05$225.00Buy$0.0000.00% ROIIQVIQVIA7/23/2025Boost Price Target$194.46$225.00Buy$0.0000.00% ROITMOThermo Fisher Scientific7/8/2025Downgrade$426.65$460.00Neutral$0.0000.00% ROIMTDMettler-Toledo International5/20/2025Upgrade$1,159.20$1,350.00Buy$0.0000.00% ROITXG10x Genomics5/13/2025Lower Price Target$9.68$12.00Neutral$0.0000.00% ROITECHBio-Techne5/9/2025Lower Price Target$49.98$70.00Buy$00.0000.00% ROIIQVIQVIA5/7/2025Lower Price Target$149.18$185.00Buy$000.0000.00% ROIBIOBio-Rad Laboratories5/2/2025Lower Price Target$236.83$310.00Buy$000.0000.00% ROIRVTYRevvity5/1/2025Upgrade$93.34$115.00Buy$00.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.50$70.00Buy$00.0000.00% ROITMOThermo Fisher Scientific4/24/2025Lower Price Target$421.04$500.00Buy$000.0000.00% ROIDHRDanaher4/23/2025Lower Price Target$203.97$240.00Buy$000.0000.00% ROIIQVIQVIA2/7/2025Lower Price Target$208.92$255.00Buy$000.0000.00% ROIAVTRAvantor1/17/2025Reiterated Rating$22.60$25.00Neutral$00.0000.00% ROICRLCharles River Laboratories International1/17/2025Reiterated Rating$165.60$185.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenRoyal Bank Of CanadaStifel NicolausBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper Sandler Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
